chr3-14819719-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152536.4(FGD5):āc.648T>Gā(p.Asp216Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000795 in 1,383,302 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152536.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FGD5 | NM_152536.4 | c.648T>G | p.Asp216Glu | missense_variant | 1/20 | ENST00000285046.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FGD5 | ENST00000285046.10 | c.648T>G | p.Asp216Glu | missense_variant | 1/20 | 1 | NM_152536.4 | P1 | |
FGD5 | ENST00000543601.5 | c.-76T>G | 5_prime_UTR_variant | 1/19 | 1 | ||||
FGD5 | ENST00000640506.1 | c.777T>G | p.Asp259Glu | missense_variant | 2/2 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000662 AC: 1AN: 151000Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000141 AC: 2AN: 141460Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 73642
GnomAD4 exome AF: 0.00000795 AC: 11AN: 1383302Hom.: 0 Cov.: 30 AF XY: 0.00000735 AC XY: 5AN XY: 680124
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 08, 2024 | The c.648T>G (p.D216E) alteration is located in exon 1 (coding exon 1) of the FGD5 gene. This alteration results from a T to G substitution at nucleotide position 648, causing the aspartic acid (D) at amino acid position 216 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at